Founded by a team of experts in aging biology, machine learning and drug development and based on pioneering research for resetting cell health by Dr. Janine Sengstack of UCSF. Junevity’s RESET platform uses large-scale human data and AI to identify novel transcription factor targets and repress them with siRNA. The initial focus is Type 2 diabetes, obesity and frailty, with the potential to address numerous indications.
Congratulations, to Dr. Janine Sengstack, the UCSF founder.